Veravas, Inc.
Blood-based biomarker diagnostic tests for early detection of Alzheimer's and other dementias
- Sector
- Medtech
- Headquarters
- Austin, TX
- Founded
- 2017
- Latest Form D
- $20.6M, Apr 2024
- Total capital
- $21.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $21.7M
- 3 Form D · last Apr 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 24 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$20.6M
- Private capital raisedForm D · SEC · 2nd filing$775K
- Private capital raisedForm D · SEC · 1st filing$375K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Carroll E. Streetman, Jr.Executive OfficerNamed in SEC Form D filings
- Frederick Allen BaumbachExecutive OfficerNamed in SEC Form D filings
- James KyleDirectorNamed in SEC Form D filings
- Jeremy CooteDirectorNamed in SEC Form D filings
- John ForrestExecutive OfficerNamed in SEC Form D filings
- Luc VanhalExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Will KikerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 24- PendingSystems And Methods For Multiplex Detection Of BiomarkersUSPTOApplication 19270869
- PendingMethods For Depletion And EnrichmentUSPTOApplication 19185839
- PendingCoronavirus Point-of-care Agglutination AssayUSPTOApplication 18041025
Show all 24 patent records
- Systems And Methods For Multiplex Detection Of BiomarkersJun 11, 2026 · Application 19270869Pending
- Methods For Depletion And EnrichmentOct 9, 2025 · Application 19185839Pending
- Coronavirus Point-of-care Agglutination AssaySep 28, 2023 · Application 18041025Pending
- Enrichment Of Antigen-specific Antibodies For Analytic And Therapeutic UseMar 23, 2023 · Application 17917479Pending
- Methods For Depletion And EnrichmentAug 18, 2022 · Application 17263667Pending
- Compositions And Methods For Detecting And Depleting Sample InterferencesAug 11, 2022 · Application 17636012Pending
- Method For Detecting BiomarkersSep 30, 2021 · Application 17263809Pending
- Sample Depletion And Enrichment To Improve The Quality Of Diagnostic Test ResultsJul 1, 2021 · Application 17199228Pending
- Methods For Depletion And EnrichmentJun 24, 2021 · Application 17160196Pending
- Enrichment Of Antigen-specific Antibodies For Analytic And Therapeutic UseApplication PCTUS2021026927Pending
- Detection Of Disease State Macromolecules Binding To Normal Macromolecules As A Biomarker For Disease IdentificationApplication PCTUS2024050852Pending
- Coronavirus Point-of-care Agglutination AssayApplication 63065993Pending
- Compositions And Methods For Detecting And Depleting Sample InterferencesApplication PCTUS2020039503Pending
- Enrichment Of Antigen-specific Antibodies For Analytic And Therapeutic UseApplication 63008472Pending
- Compositions And Methods For Detecting And Depleting Sample InterferencesApplication 63006630Pending
- Method For Detecting BiomarkersApplication PCTUS2019043715Pending
- Methods For Depletion And EnrichmentApplication PCTUS2019043711Pending
- Compositions And Methods For Detecting And Depleting Sample InterferencesApplication 62866318Pending
- Methods For Depletion And EnrichmentApplication 62711391Pending
- Systems And Methods For Multiplex Detection Of BiomarkersApplication 63481360Pending
- Method For Detecting BiomarkersApplication 62711415Pending
- Systems And Methods For Multiplex Detection Of BiomarkersApplication 63480437Pending
- Systems And Methods For Multiplex Detection Of BiomarkersApplication PCTUS2024012072Pending
- Coronavirus Point-of-care Agglutination AssayApplication PCTUS2021046177Pending
Related companies, and why
- XENTER, INC.Similar federal contract value in Medtech · null in contracts
- Sommetrics, Inc.Similar federal contract value in Medtech · null in contracts
- Therma Bright Inc.Similar federal contract value in Medtech · null in contracts
- Adaptiiv Medical Technologies US, Inc.Similar federal contract value in Medtech · null in contracts
- AIQ GLOBAL INCSimilar federal contract value in Medtech · null in contracts
- Innovative Trauma Care Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .